All Reports Events Blogs Videos
Showing 16 results
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Thematic Report
    March 31, 2026

    In today’s evolving talent landscape, organizations must consistently track key roles and skill sets across both established and emerging areas to make informed workforce-planning decisions. Elevated demand often reflects intensified competition for talent and potential attrition…
  • Voice of the Partner
    Dec. 15, 2025

    Global technology ecosystems are rapidly transforming as enterprises increasingly rely on channel partners to deliver integrated, outcome-driven solutions. As technology stacks expand and customer expectations rise, technology providers are reshaping their partner engagement models to drive…
  • Tech Launch Perspective
    Sep. 25, 2025

    Zoho’s July 2025 product announcements signal a decisive move toward becoming an AI-first enterprise platform, with a particular focus on agentic AI. This report evaluates how Zoho’s ecosystem, including Zia Agents, Zia Agent Studio, and Zia…
  • Thematic Report
    Sep. 12, 2025

    In today’s dynamic talent landscape, organizations must continuously track both in-demand and emerging roles and skills to enable strategic workforce planning. Rising demand often signals heightened competition or increased attrition risk, making it critical to analyze…
  • Viewpoint
    May 07, 2025

    Increasing trial complexity, growing data volumes, and the rise of decentralized and real-world data sources are fundamentally transforming the clinical trial landscape. Traditional Clinical Data Management (CDM) processes are largely manual and rely on siloed data…
  • April 09, 2025

    In today’s dynamic talent market, organizations must actively monitor key roles and skills, both in-demand and emerging, to enable strategic workforce planning. Higher demand may indicate more significant competition for talent or a higher risk of…
  • Viewpoint
    July 03, 2024

    Gen AI can create diverse content and data formats, revolutionizing the AI landscape and transforming businesses. The pharmaceutical industry can use gen AI to sift through vast clinical data volumes, enabling trial protocols’ drafting and improving clinical…
  • Thematic Report
    June 20, 2024

    Patient recruitment is a complex and dynamic part of clinical trial management, requiring proactive strategies, collaborations, and innovation to overcome challenges and achieve enrollment targets. Patient recruitment is vital for clinical trials, yet it presents challenges…
  • PEAK Matrix®
    June 03, 2024

    The evolving regulatory landscape poses significant challenges for life sciences enterprises. Enterprises struggle to navigate complex compliance frameworks, stay updated with emerging regulations, and manage diverse geographical requirements, all vital for achieving regulatory compliance and securing…
  • Viewpoint
    Nov. 08, 2023

    In recent years, the emergence of digital tools and technologies has brought significant change in clinical research and trials. While traditional clinical trials have long been the gold standard for evaluating medical interventions, the proliferation of…
  • Viewpoint
    Oct. 31, 2022

    Remote Patient Monitoring (RPM) is an integrated approach that employs technology-backed medical devices to gather physiological and biometric data from patients that is electronically transmitted for remote analysis, review, and, when necessary, interventions and preventive care.…
  • Viewpoint
    Sep. 30, 2022

    The rising burden of chronic diseases worldwide is driving life sciences companies’ drug development efforts. These drug development efforts need to abide by the strict drug safety regulations of public health organizations, such as the US…
  • PEAK Matrix®
    March 19, 2021

    Traditionally considered to be a cost-function by life sciences enterprises, the pharmacovigilance and device-vigilance / complaint management market is finally getting its long-due attention from all industry sections – including regulatory agencies, drug safety teams, and…
  • Viewpoint
    Oct. 16, 2020

    The evidence and insights from clinical trials form the backbone of care delivery, as regulatory bodies use them to approve drugs and physicians use them to decide clinical interventions and make prescription decisions. In an ideal…